The U.S. Food and Drug Administration has approved Sana Biotechnology’s investigational new drug (IND) application requesting a Phase…
Articles by Marisa Wexler, MS
People with ANCA-associated vasculitis (AAV) that affects their kidneys are at a significantly increased risk of kidney failure if…
High blood levels of the immune protein C4 are significantly associated with greater kidney-specific disease activity and a higher chance…
A treatment regimen that combines low-dose glucocorticoids and rituximab is just as effective at controlling ANCA-associated vasculitis (AAV) as…
Researchers in Korea have developed a new system to classify ANCA-associated vasculitis (AAV) into clusters, and provided an algorithm…
Subclinical changes are evident in the small blood vessels in the back of the eye and in the nails of…
The prognostic immune nutritional index or PINI — a novel clinical tool based on counts of immune cells and levels…
People with ANCA-associated vasculitis (AAV) who develop low antibody levels associated with rituximab treatment are at high risk…
A combination of two standardized scores of kidney damage can accurately predict the prognosis of renal disease in people with…
A new statistical model that considers age, disease type, patterns of organ involvement, and lab findings may help predict long-term…